Sugi Predict

Sugi Predict / Compounds / SCHEMBL994958

SCHEMBL994958

SCHEMBL994958

c1ccc(-c2c3ccccc3c(-c3ccccc3)c3cc(-c4ccc5c(-c6ccccc6)c6ccccc6c(-c6ccccc6)c5c4)ccc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 2/20 0.45
▸ ESR1 P03372 6/20 0.44
▸ ESR2 Q92731 6/20 0.44
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ HSD17B1 P14061 1/20 0.42
▸ CYP2B6 P20813 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ HSD17B2 P37059 1/20 0.42
▸ MAPT P10636 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ ALOX5 P09917 1/20 0.39
▸ JAK2 O60674 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29662092 1.00 ACHE (0.45) ACHEESR1ESR2CYP1A2CYP3A4
SCHEMBL21435747 0.98 ESR2 (0.46) ACHEESR1ESR2CYP1A2CYP3A4
SCHEMBL28085916 0.98 ESR2 (0.46) ACHEESR1ESR2CYP1A2CYP3A4
SCHEMBL5599347 0.98 ESR2 (0.46) ACHEESR1ESR2CYP1A2CYP3A4
SCHEMBL19283276 0.98 ESR2 (0.46) ACHEESR1ESR2CYP1A2CYP3A4
SCHEMBL2964995 0.98 ESR2 (0.46) ACHEESR1ESR2CYP1A2CYP3A4
SCHEMBL21435746 0.95 HSD17B1 (0.43) ACHEESR1ESR2CYP1A2CYP3A4
SCHEMBL28590274 0.95 ESR2 (0.47) ACHEESR1ESR2CYP1A2CYP3A4
SCHEMBL4585463 0.95 ESR2 (0.47) ACHEESR1ESR2CYP1A2CYP3A4
SCHEMBL21332240 0.93 ESR1 (0.43) ACHEESR1ESR2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12396075-B2 Blue organic electroluminescence device, display panel and display apparatus BOE TECHNOLOGY GROUP CO., LTD. (CN) 2025-08-19 — — US claimed
EP-4592297-A1 AN ORGANIC BORON COMPOUND, AN ORGANIC LIGHT EMITTING DIODE COMPRISING THE ORGANIC BORON COMPOUND, A USE OF THE DIODE, AND A CONSUMER PRODUCT Noctiluca S.A. (PL) 2025-07-30 — — EP claimed
US-20220418059-A1 BLUE ORGANIC ELECTROLUMINESCENCE DEVICE, DISPLAY PANEL AND DISPLAY APPARATUS BOE TECHNOLOGY GROUP CO., LTD. (CN) 2022-12-29 — — US claimed
CN-107978684-B Electron transport layer stack for organic light emitting diodes 诺瓦尔德股份有限公司 2022-08-23 — — CN claimed
WO-2022126499-A1 BLUE ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY PANEL AND DISPLAY APPARATUS 京东方科技集团股份有限公司 2022-06-23 — — WO claimed
US-11355721-B2 Organic light emitting device comprising polar matrix, metal dopant and silver cathode NOVALED GMBH (DE) 2022-06-07 — — US claimed
EP-3109919-B1 N-DOPED SEMICONDUCTING MATERIAL COMPRISING POLAR MATRIX AND METAL DOPANT NOVALED GMBH (DE) 2021-06-23 — — EP claimed
CN-111900255-A Organic light emitting device comprising a polar host, a metal dopant and a silver cathode 诺瓦尔德股份有限公司 2020-11-06 — — CN claimed
US-10749115-B2 N-doped semiconducting material comprising polar matrix and metal dopant NOVALED GMBH (DE) 2020-08-18 — — US claimed
CN-107851733-B Organic light emitting device comprising a polar host, a metal dopant and a silver cathode 诺瓦尔德股份有限公司 2020-07-17 — — CN claimed
EP-3109919-A1 N-DOPED SEMICONDUCTING MATERIAL COMPRISING POLAR MATRIX AND METAL DOPANT Novaled GmbH (DE) 2016-12-28 — — EP claimed
US-20160322568-A1 N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant NOVALED GMBH (DE) 2016-11-03 — — US claimed
EP-3087621-A1 N-DOPED SEMICONDUCTING MATERIAL COMPRISING PHOSPHINE OXIDE MATRIX AND METAL DOPANT Novaled GmbH (DE) 2016-11-02 — — EP claimed
EP-2887416-A1 N-doped semiconducting material comprising phosphine oxide matrix and metal dopant Novaled GmbH (DE) 2015-06-24 — — EP claimed
US-20070126347-A1 OLEDS with improved efficiency EASTMAN KODAK COMPANY 2007-06-07 — — US claimed
US-7183010-B2 Organic light-emitting diode devices with improved operational stability EASTMAN KODAK CORPORATION (US) 2007-02-27 — — US claimed
US-7175922-B2 Aggregate organic light emitting diode devices with improved operational stability EASTMAN KODAK COMPANY (US) 2007-02-13 — — US claimed
US-20060141287-A1 OLEDs with improved operational lifetime EASTMAN KODAK COMPANY 2006-06-29 — — US claimed
US-20050106415-A1 Aggregate organic light emitting diode devices with improved operational stability EASTMAN KODAK COMPANY 2005-05-19 — — US claimed
US-20040076853-A1 Organic light-emitting diode devices with improved operational stability EASTMAN KODAK COMPANY 2004-04-22 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160322568-A1 N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant NNMT, PNN, PNMT ACHE 1062/4885ESR1 1805/4885ESR2 2491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.